Camber Capital Management’s Sanofi SNY Stock Holding History

Camber Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,750,000	Closed	-$148M	–	42
2023 Q3	$148M	Sell	2,750,000 -1,250,000	-31%	-$66.6M	4.86%	6
2023 Q2	$216M	Sell	4,000,000 -1,500,000	-27%	-$80.7M	7.02%	4
2023 Q1	$299M	Sell	5,500,000 -1,500,000	-21%	-$73M	9.2%	2
2022 Q4	$339M	Sell	7,000,000 -500,000	-7%	-$21.9M	11.63%	1
2022 Q3	$285M	Buy	7,500,000 +3,500,000	+88%	+$156M	8.73%	1
2022 Q2	$200M	Hold	4,000,000	–	–	8.68%	2
2022 Q1	$205M	Buy	4,000,000 +200,000	+5%	+$10.3M	7.43%	3
2021 Q4	$190M	Buy	3,800,000 +800,000	+27%	+$39.6M	6.54%	4
2021 Q3	$145M	Buy	3,000,000 +750,000	+33%	+$38.1M	4.45%	7
2021 Q2	$118M	Buy	+2,250,000	New	+$117M	3.99%	8

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Camber Capital Management's SNY Position: Q4 2023 in Review

Camber Capital Management sold out of Sanofi (SNY) in Q4 2023, closing a stake of 2,750,000 shares — an estimated $148M sold.

Camber Capital Management first reported a position in SNY in Q2 2021 and held it in 10 quarters. The position peaked at $339M in Q4 2022. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

Camber Capital Management reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
Camber Capital Management sold 2,750,000 Sanofi shares in Q4 2023, an estimated $148M.
Camber Capital Management first reported a position in Sanofi in Q2 2021 and held it in 10 quarters.
Camber Capital Management's Sanofi position peaked at $339M in Q4 2022.
709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Camber Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.